The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.
Not only is daylight photodynamic therapy as effective as conventional photodynamic therapy (using blue light) for the treatment of actinic keratosis but it is less painful, a novel study finds.
A vismodegib regimen that includes a weekend drug holiday showed similar responses to treatment for patients with advanced basal cell carcinoma and basal cell nevus syndrome and provided a more tolerable adverse effect profile.
There is a decreased risk for melanoma diagnosis among bereaved individuals but increased mortality associated with melanoma compared with nonbereaved individuals.
The FDA has accepted for filing the New Drug Application for tirbanibulin ointment (formerly known as KX2-391 or KX-01 ointment; Athenex) for the treatment of actinic keratosis (AK).
Physicians may be reassured, when prescribing methotrexate to their patients with psoriasis, as no association between methotrexate exposure and risk for cutaneous malignant melanoma was noted in a sizeable study.
The researchers found that compared with heterosexual men, gay and bisexual men had significantly higher adjusted odds ratios of skin cancer prevalence.
